John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Endava
DAVA
$168M
| $7.84M | 0.02% |
102,167
+98,099
| +2,411% | +$6.63M |
|
702
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$292M
| $7.84M | 0.02% |
294
+86
| +41% | +$3.13M |
|
|
WPX
703
DELISTED
WPX Energy, Inc.
WPX
| $7.82M | 0.02% |
959,087
+744,198
| +346% | +$4.73M |
|
704
UnitedHealth
UNH
$358B
| $7.81M | 0.02% |
22,272
-291,901
| -93% | -$97.8M |
|
|
NXH
705
PUT
Neighborhood Intelligence Inc
NXH
$372M
| $7.79M | 0.02% |
178,530
+149,270
| +510% | +$8.83M |
|
706
CALL
United Airlines
UAL
$36.9B
| $7.69M | 0.02% |
177,900
-19,400
| -10% | -$785K |
|
707
CALL
Snap
SNAP
$9.35B
| $7.69M | 0.02% |
153,500
+46,300
| +43% | +$1.92M |
|
708
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
| $7.67M | 0.02% |
33,100
-52,600
| -61% | -$11.6M |
|
709
Huntington Bancshares
HBAN
$34.4B
| $7.67M | 0.02% |
607,198
+322,397
| +113% | +$3.66M |
|
|
HIMX
710
Himax Technologies
HIMX
$2.34B
| $7.63M | 0.02% |
1,032,111
+524,498
| +103% | +$2.68M |
|
711
Manulife Financial
MFC
$71B
| $7.61M | 0.02% |
+427,200
| New | +$6.82M |
|
712
CALL
JPMorgan Chase
JPM
$947B
| $7.61M | 0.02% |
59,900
-21,000
| -26% | -$2.35M |
|
|
SPLK
713
PUT
DELISTED
Splunk Inc
SPLK
| $7.58M | 0.02% |
44,600
+38,300
| +608% | +$7.32M |
|
714
Altria Group
MO
$114B
| $7.56M | 0.02% |
184,421
-2,921,676
| -94% | -$117M |
|
715
T. Rowe Price
TROW
$24B
| $7.55M | 0.02% |
49,851
-263,774
| -84% | -$37.7M |
|
|
ORC
716
Orchid Island Capital
ORC
$1.34B
| $7.54M | 0.02% |
288,741
+116,880
| +68% | +$3.1M |
|
|
TVTY
717
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $7.53M | 0.02% |
384,590
-81,148
| -17% | -$1.35M |
|
718
Paylocity
PCTY
$8.09B
| $7.49M | 0.02% |
36,362
-11,050
| -23% | -$2.13M |
|
|
HDV
719
iShares Core High Dividend ETF
HDV
$15.4B
| $7.46M | 0.02% |
425,760
-326,500
| -43% | -$5.53M |
|
720
Fidelity National Information Services
FIS
$21.4B
| $7.46M | 0.02% |
52,760
+50,755
| +2,531% | +$7.24M |
|
721
CALL
Lam Research
LRCX
$388B
| $7.46M | 0.02% |
+158,000
| New | +$6.65M |
|
722
American Homes 4 Rent
AMH
$12.5B
| $7.45M | 0.02% |
248,439
+221,691
| +829% | +$6.5M |
|
723
Crane NXT
CXT
$2.87B
| $7.43M | 0.02% |
275,460
-150,986
| -35% | -$3.33M |
|
724
PUT
State Street Energy Select Sector SPDR ETF
XLE
$41.5B
| $7.42M | 0.02% |
391,800
+323,800
| +476% | +$5.58M |
|
725
Enovis
ENOV
$1.45B
| $7.42M | 0.02% |
+112,801
| New | +$6.59M |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.